Search

everythinglearnresearchcommunity

for

Search:↓

Type I interferons play a key role in the development of various skin diseases.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Skin conditions can signal heart issues, highlighting the need for integrated care.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Deep learning effectively diagnoses scalp disorders, but improvements are needed.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

TNF-alpha inhibitors can cause various immune-related skin issues.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

Induced pluripotent stem cells are a major breakthrough in regenerative medicine.

Cyclosporine is effective for skin conditions but has declined in use due to toxicity concerns.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Topical minoxidil can cause severe liver failure.

Infectious cerebral vasculitis can be a severe complication of meningoencephalitis, regardless of the pathogen.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.